[Therapeutic use of tiapride in movement disorders].
Tiapridal was given to twenty-four patients suffering from dyskinesias. Therapeutic efficacity seems to the etiology. Not any fonctitonal improvement was observed in parkinsonism with dyskinesia consecutive to Dopa therapy. On the other hand a good efficacity was found in the treatment of choreas with a quite good tolerance; the functional result will depend of the evolutive state of the disease.
D001549:Benzamides / Q000627:therapeutic use*; D002819:Chorea / Q000188:drug therapy; D002908:Chronic Disease; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy; D007980:Levodopa / Q000627:therapeutic use; D009069:Movement Disorders / Q000188:drug therapy*; D010300:Parkinson Disease / Q000188:drug therapy
D001549:Benzamides; D007980:Levodopa
Utilisation du tiapride dans le traitement de certains mouvements anormaux.